Table 3 Univariate and multivariate competing risk regression for predicting 90-day mortality in the total cohort.

From: Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure

Variables

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

1.022 (1.004–1.040)

0.045

1.021 (1.000–1.043)

0.042

Liver cirrhosis

0.942 (0.599–1.481)

0.796

  

Ascites

2.096 (1.197–3.670)

0.010

0.999 (0.559–1.784)

0.996

AKI

2.500 (1.675–3.732)

 < 0.001

1.231 (0.760–1.996)

0.398

Infection

2.056 (1.196–3.534)

0.009

1.321 (0.775–2.310)

0.329

Diabetes

1.438 (0.929–2.226)

0.103

  

AARC score

1.521 (1.356–1.706)

 < 0.001

1.498 (1.312–1.710)

 < 0.001

Overweight

0.692 (0.447–1.072)

0.099

  

Sarcopenia

2.219 (1.533–3.212)

 < 0.001

1.802 (1.062–3.060)

0.029

Visceral obesity

0.752 (0.525–1.078)

0.121

  

Myosteatosis

2.076 (1.369–3.149)

0.001

1.477 (0.900–2.424)

0.123

Sarcopenic obesity

2.000 (1.268–3.154)

0.003

0.786 (0.412–1.500)

0.466

  1. Age, ascites, AKI, infection, AARC score, sarcopenia, myosteatosis, and sarcopenic obesity were included in the multivariate analysis.
Back to article page